The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Management of Insomnia | New England Journal of Medicine
2024年7月17日 · Insomnia is common and frequently occurs with other disorders. First-line cognitive behavioral therapy with or without medication can produce rapid, sustained alleviation of insomnia symptoms.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH …
2024年2月7日 · From the University of Oxford, Oxford (S.A.H.), the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne (Q.M.A.), and the National ...
Hydrocortisone in Severe Community-Acquired Pneumonia | New …
2023年3月21日 · New perspectives on community-acquired pneumonia in 388 406 patients: results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009;64:1062-1069. Crossref
The Emerging Threat of H5N1 to Human Health | New England …
2024年12月31日 · Against this background, more humans have come into contact with HPAI A(H5N1). Investigators now report in the Journal a series of human cases from the United States and Canada. 2,3 The former ...
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell …
2024年9月13日 · Durvalumab is a selective, high-affinity human IgG1 monoclonal antibody that binds to programmed death ligand 1 (PD-L1), blocking its interaction with programmed death 1 (PD-1) and CD80 on ...
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without ...
2024年6月14日 · New England Journal of Medicine. Volume 391 • Number 3 • July 18 ... VIC (B.C.V.C), and the Department of Neurology, University of New South Wales South Western Sydney Clinical School ...
Pulmonary Arterial Hypertension | New England Journal of Medicine
2021年12月15日 · Other new mutations involve ATP13A3 (encoding ATPase 13A3); SOX17, which encodes SRY-box 17 and is a major risk factor for congenital heart disease–associated pulmonary arterial hypertension) 51 ...
Daratumumab or Active Monitoring for High-Risk Smoldering …
2024年12月9日 · Among the 390 enrolled patients, 194 were assigned to the daratumumab group and 196 to the active-monitoring group. With a median follow-up of 65.2 months, the risk of disease progression or death ...
Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis
2022年9月14日 · A total of 249 patients were included in the interim analysis. The trial was halted owing to between-group differences in the safety outcomes without a significant difference in the incidence of ...